Days At A Glance Speakers Session Type Search
Type

    09:00 - 13:00 
    Registration
    11:00 - 13:00 
    BONE AND MINERAL SPECIAL INTEREST GROUP
    HALL 11
    Chairs: M Cooper (Birmingham) & B Evans (Cardiff)
    SIG1.1
    BONE AND MINERAL SPECIAL INTEREST GROUP
    Osteopetrosis and other causes of high bone mass
    SIG1.2
    BONE AND MINERAL SPECIAL INTEREST GROUP
    Hypophosphataemic rickets
    New Haven, USA
    SIG1.3
    BONE AND MINERAL SPECIAL INTEREST GROUP
    Osteogenesis imperfecta
    SIG1.4
    BONE AND MINERAL SPECIAL INTEREST GROUP
    Osteoporosis
    Rotterdam, Netherlands
    11:00 - 13:00 
    OBESITY SPECIAL INTEREST GROUP
    HALL 1
    Chairs: S Aylwin (London) & K Murphy (London)
    SIG2.1
    OBESITY SPECIAL INTEREST GROUP
    Gut hormone based polypharmacy - same benefits without the surgery?
    Cincinatti, USA
    SIG2.2
    OBESITY SPECIAL INTEREST GROUP
    Gut, hormones, weight loss and metabolic improvement after bariatric surgery
    SIG2.3
    OBESITY SPECIAL INTEREST GROUP
    Pre- and post-operative management of patients undergoing bariatric surgery
    SIG2.4
    OBESITY SPECIAL INTEREST GROUP
    Bariatric surgery - a cure for diabetes?
    11:00 - 13:00 
    LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
    HALL 9
    Chairs: J Barth (Leeds) & R Gorrigan (London)
    SIG3.1
    LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
    Definition of Vitamin D deficiency
    SIG3.2
    LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
    Definition of male hypogonadism
    Torrence, USA
    SIG3.3
    LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
    Definition of hypothyroidism
    SIG3.4
    LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
    Definition of hyperandrogenism
    13:00 - 13:30 
    LUNCH
    HALL 3
    13:30 - 15:30 
    Symposium 1
    ALL YOU NEED TO KNOW ABOUT THE GENETICS OF DIABETES (TYPE 1 & 2 AND MODY)
    HALL 11
    Chairs: S Farooqi (Cambridge) & S Finer (London)
    S1.1
    Symposium 1
    Immune mechanisms involved in Type 1 diabetes - insights from genetics
    S1.2
    Symposium 1
    The diverse phenotypes of potassium ATP channel mutations
    S1.3
    Symposium 1
    Using biomarkers to differentiate subtypes of MODY
    S1.4
    Symposium 1
    Genome-wide association studies for Type 2 diabetes
    13:30 - 15:30 
    Clinical Management Workshop 1
    THE MANAGEMENT OF DIFFICULT GRAVES' DISEASE
    SUPPORTED BY CLINICAL ENDOCRINOLOGY AND THYROID EYE DISEASE CHARITABLE TRUST
    HALL 1
    Chairs: R Ajjan (Leeds) & T Galliford (London)
    CM1.1
    Clinical Management Workshop 1
    Autoimmune hyperthyroidism - a spectrum of causes
    Newcastle, UK
    CM1.2
    Clinical Management Workshop 1
    Thyroid storm, aranulocytosis, vasculitis, hepatitis - what to do next?
    CM1.3
    Clinical Management Workshop 1
    The management of Graves' opthalmopathy and dermopathy
    Varese, Italy
    CM1.4
    Clinical Management Workshop 1
    New therapies for Graves' Disease
    13:30 - 15:30 
    Applied Physiology Workshop
    SEEING IS BELIEVING - CUTTING EDGE IN VIVO CELL IMAGING
    HALL 9
    Chairs: J Davis (Manchester) & M Gurnell (Cambridge)
    AP1.1
    Applied Physiology Workshop
    Cellular imaging in the pituitary - in vivo confocal microscopy
    Montpellier, France
    AP1.2
    Applied Physiology Workshop
    Imaging of cell migration and invasion
    Nijmegen, Netherlands
    AP1.3
    Applied Physiology Workshop
    CARS microscopy as a novel tool in cell imaging
    15:30 - 16:00 
    TEA & COFFEE
    HALL 3
    16:00 - 18:00 
    Symposium 2
    NOVEL PATHWAYS AND TREATMENTS IN NEUROENDOCRINE TUMOURS
    SUPPORTED BY THE ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS
    HALL 11
    Chairs: P Trainer (Manchester) & U Srirangalingam (London)
    S2.1
    Symposium 2
    Signalling pathways in neuroendocrine tumours
    New Haven, USA
    S2.2
    Symposium 2
    DNA methylation profiling of neuroendocrine tumours
    S2.3
    Symposium 2
    Tyrosine kinase inhibitors for neuroendocrine tumours
    S2.4
    Symposium 2
    New horizons in therapy
    16:00 - 18:00 
    Oral Communications 1
    YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
    HALL 1
    Chairs: I Clarke (Melbourne, Australia) & J Fagin (New York, NY, USA)
    OC1.1
    Oral Communications 1
    Thyroid hormones in the euthyroid range predict subsequent body mass composition in women - the OPUS study
    OC1.2
    Oral Communications 1
    Does ‘mild’ primary hyperparathyroidism progress if left untreated? A natural history study
    OC1.3
    Oral Communications 1
    Prolonged exposure to growth hormone (GH) impairs insulin signalling in the heart
    OC1.4
    Oral Communications 1
    Developing an in vitro model of tissue expansion in Graves ophthalmopathy - exploring the role of IGF-1 receptor targeting as a novel treatment.
    OC1.5
    Oral Communications 1
    Athertoprotection by 11β-HSD1 deficiency in APOE-/- mice - role of both glucocorticoid and 7-oxysterol factors
    OC1.6
    Oral Communications 1
    Evidence for the existence and significance of an alternative pathway towards androgen synthesis during early human life
    OC1.7
    Oral Communications 1
    Mutant cytochrome b5 causing 46,XY disorder of sex development (DSD) due to apparent CYP17A1 17,20 lyase
    OC1.8
    Oral Communications 1
    TSH levels and thyroid hormone prescribing in primary care in the UK
    16:00 - 18:00 
    Oral Communications 2
    STEROIDS
    HALL 9
    Chairs: S Hillier (Edinburgh) & M De Bono (Sheffield)
    OC2.1
    Oral Communications 2
    Regulation of 11beta-hydroxysteroid dehydrogenase type 1 by NF-kB in stromal cells - towards tissue specific enzyme
    OC2.2
    Oral Communications 2
    Anti-inflammatory mechanisms of 5α-Reduced glucocorticoids - potential dissociated steroids
    OC2.3
    Oral Communications 2
    APEX1, a novel, negative regulator of aldosterone synthase activity, differentially binds to a single nucleotide polymorphism in the aldosterone synthase gene and represses transcriptional activity both in vitro and in vivo
    OC2.4
    Oral Communications 2
    Altered miR-125 and miR-134 expression in aldosterone-producing adenoma and post-transcriptional regulation of the CYP11B2 gene
    OC2.5
    Oral Communications 2
    A novel entity of isolated adrenal insufficiency caused by partial inactivation of P450 side-chain cleavage (CYP11A1) enzyme
    OC2.6
    Oral Communications 2
    Novel non-steroidal glucocorticoids that dissociate rapid signalling effects from gene transcription
    OC2.7
    Oral Communications 2
    Depot specific differences in the sensitivity to glucocorticoid and insulin action in human adipose tissue
    OC2.8
    Oral Communications 2
    Metformin increases in vivo 11β-hydroxysteroid dehydrogenase type 1 activity in euglycaemic obese men
    18:10 - 19:10 
    YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
    HALL 1
    Chairs: A McNeilly (Edinburgh) & P Trainer (Manchester)
    YEP1.1
    YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
    Novel glucocorticoid effects - signaling from the membrane to the nucleus
    YEP1.2
    YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
    Clinical, genetic and molecular characterisation of patients with familial isolated pituitary
    19:15 - 23:00 
    WELCOME RECEPTION
    HALL 3
    19:45 - 23:00 
    YE SOCIAL EVENING
    HALL 11

    07:00 - 07:15 
    Breakfast
    HALL 9, 10 & 11 FOYER
    07:15 - 08:00 
    Meet the Expert 1
    ABNORMAL GROWTH AND PUBERTY PRESENTING IN 'LATE ADOLESCENCE'
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 9
    Chair: H Gleeson (Manchester)
    Expert: P Clayton (Manchester)
    07:15 - 08:00 
    Meet the Expert 2
    THE DIFFICULT CUSHING'S OR NELSON'S PATIENT
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 11
    Chair: A Grossman (London)
    Expert: X Bertanga (Paris, France)
    07:15 - 08:00 
    Meet the Expert 3
    VITAMIN D DEFICIENCY, WHEN AND HOW TO TREAT
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 10
    Chair: S Orme (Leeds)
    Expert: P Selby (Manchester)
    08:15 - 10:15 
    Symposium 3
    FAT ENDOCRINOLOGY: DISORDERS OF ADIPOSE TISSUE AND LIPIDS IMPORTANT TO THE ENDOCRINOLOGIST
    HALL 1
    Chairs: W Dhillo (London) & A Sam (London)
    S3.1
    Symposium 3
    Can we make more brown adipose tissue to treat obesity?
    Maastrict, Netherlands
    S3.2
    Symposium 3
    Familial partial lipodystrophy - an introduction and the importance of diagnosing FPLD
    S3.3
    Symposium 3
    The link between insulin resistance, dyslipidaemia and fatty liver
    Edinburgh, UK
    S3.4
    Symposium 3
    What you need to know about the genetics of hyperlipidaemia
    08:15 - 10:15 
    Oral Communications 3
    PITUITARY AND THYROID
    HALL 9
    Chairs: P Belchetz (Leeds) & A Mitchell (Newcastle)
    OC3.1
    Oral Communications 3
    Development of a novel mass spectroscopy-based method for determining serum IGF-1 - assessment in a cohort of newly diagnosed subjects with acromegaly.
    OC3.2
    Oral Communications 3
    Determination of method-specific normal cortisol responses to the short Synacthen test
    OC3.3
    Oral Communications 3
    miR-107 inhibits the expression of aryl hydrocarbon receptor interacting protein (AIP) and is potentially involved in pituitary tumorigenesis
    OC3.4
    Oral Communications 3
    PTTG promotes mitogenic mechanisms in thyroid cells through autocrine pathways of interaction with growth factors
    OC3.5
    Oral Communications 3
    Metastatic characteristics and radiosensitivity of thyroid carcinoma cells depends on HIF-1 and PI3K signalling in vitro and in vivo
    OC3.6
    Oral Communications 3
    Morbidity in patients with endogenous subclinical hyperthyroidism
    OC3.7
    Oral Communications 3
    Thyroid dysfunction and clot structure - a mechanism for increased thrombotic risk in hyperthyroid individuals?
    OC3.8
    Oral Communications 3
    Assessment of the UK iodine status - a national survey
    08:15 - 10:15 
    Clinical Management Workshop 2
    ENDOCRINE PROBLEMS IN PREGNANCY
    SUPPORTED BY CLINICAL ENDOCRINOLOGY, THE BRITISH THYROID FOUNDATION AND ADDISON'S DISEASE SELF HELP GROUP
    HALL 11
    Chairs: T Kearney (Manchester) & S Jarvis (London)
    CM2.1
    Clinical Management Workshop 2
    Hypothyroidism and euthyroid antibody-positive patients
    CM2.2
    Clinical Management Workshop 2
    Treatment of hyperthyroidism in pregnancy-risk for the unborn
    Padova, Italy
    CM2.3
    Clinical Management Workshop 2
    Adrenal disorders in pregnancy
    CM2.4
    Clinical Management Workshop 2
    Phaeochromocytoma in pregnancy
    Nijmegen, Netherlands
    10:15 - 10:40 
    TEA & COFFEE
    HALL 3
    10:40 - 11:20 
    SOCIETY FOR ENDOCRINOLOGY DALE MEDAL LECTURE
    HALL 1
    Chair: J Buckingham (London)
    PL1
    SOCIETY FOR ENDOCRINOLOGY DALE MEDAL LECTURE
    Aromatase, obesity and breast cancer - old wine in new bottles
    Melbourne, Australia
    11:20 - 12:00 
    SOCIETY FOR ENDOCRINOLOGY HOFFENBERG INTERNATIONAL MEDAL LECTURE
    HALL 1
    Chair: M Korbonits (London)
    PL2
    SOCIETY FOR ENDOCRINOLOGY HOFFENBERG INTERNATIONAL MEDAL LECTURE
    Aldosterone action and the mineralocorticoid receptor
    Melbourne, Australia
    12:00 - 14:00 
    LUNCH & POSTERS
    HALL 3
    14:00 - 16:00 
    Symposium 4
    ENDOCRINE REGULATION OF AGEING
    HALL 10
    Chairs: J Kopchick (Athens, GA, USA) & C Moss (London)
    S4.1
    Symposium 4
    The aging process - somatotrophic axis and calorie restriction
    Springfield, USA
    S4.2
    Symposium 4
    Mechanisms: insulin sensitivity, AMPK and lifespan
    S4.3
    Symposium 4
    DHEA, DHEAS and immunosenescence
    S4.4
    Symposium 4
    Aging, hormones and cognition in humans
    14:00 - 16:00 
    Oral Communications 4
    BONE, METABOLISM AND DIABETES
    HALL 11
    Chair: P Newey (Oxford)
    OC4.1
    Oral Communications 4
    A mouse with an ENU-induced mutation (Tyr209Asn) in the Natriuretic peptide receptor 3 (Npr3) develops autosomal recessive kyphosis
    OC4.2
    Oral Communications 4
    Is MEPE a novel regulator of growth plate mineralisation?
    OC4.3
    Oral Communications 4
    Rapid bone turnover responses to increased hypothalamic-pituitary-thyroid-axis activity are mediated by thyroid hormones
    OC4.4
    Oral Communications 4
    CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus but not in adipose tissues
    OC4.5
    Oral Communications 4
    Alterations to hypothalamic 5-HT and DA turnover in offspring induced by maternal exposure to a high caloric diet throughout lactation
    OC4.6
    Oral Communications 4
    Dual effect of arachidonic acid on peroxisome proliferator-activated receptor gamma (PPARg)-dependent action in 3T3-L1 adipocytes
    OC4.7
    Oral Communications 4
    Co-administration of the gut hormones PYY and GLP-1 to human volunteers reduces food intake and brain activation in appetite centres
    OC4.8
    Oral Communications 4
    Hyperghrelinaemia, hyperphagia, food hoarding and reduced adiposity in an imprinting centre deletion mouse model of Prader Willi syndrome
    14:00 - 16:00 
    Young Endocrinologists' Symposium
    A SUCCESSFUL RESEARCH CAREER
    HALL 9
    Chairs: L Lloyd (Nottingham) & A Tahrani (Birmingham)
    YE1.1
    Young Endocrinologists' Symposium
    Research in clinical academia
    YE1.2
    Young Endocrinologists' Symposium
    Managing your research degree
    YE1.3
    Young Endocrinologists' Symposium
    Postdoctoral research - the things I wish I knew
    YE1.4
    Young Endocrinologists' Symposium
    Commercialisation and IP – translating scientific research
    16:00 - 16:30 
    TEA & COFFEE
    HALL 3
    16:30 - 18:30 
    Oral Communications 5
    REPRODUCTION AND FOETAL PROGRAMMING
    HALL 10
    Chairs: A Fowden (Cambridge) & S Chan (Birmingham)
    OC5.1
    Oral Communications 5
    The effect of a maternal low protein diet on renal development and function in the offspring
    OC5.2
    Oral Communications 5
    Maternal low protein diet and fetal growth restriction - new insights into the role of placental 11ß-hydroxysteroid dehydrogenase-2
    OC5.3
    Oral Communications 5
    Mutations in the gene encoding the Fibroblast Growth Factor 8 (FGF8) are associated with complex midline defects including recessive holoprosencephaly and hypothalamo-pituitary dysfunction
    OC5.4
    Oral Communications 5
    Impaired cardiac function in GR-/- fetal mice
    OC5.5
    Oral Communications 5
    Absence of 11β-HSD2 specifically within the foetal brain alters adult 'depressive' behaviour
    OC5.6
    Oral Communications 5
    Consequence of embryonic exposure to 17β-estradiol on brain asymmetry development and neuroendocrine gene
    OC5.7
    Oral Communications 5
    Plasma biomarkers for early prediction of preleclampsia
    OC5.8
    Oral Communications 5
    Altered fetoplacental growth in monocarboxylate transporter 8 (Mct8) knockout mice
    16:30 - 18:30 
    Symposium 5
    THE NOVEL ROLE OF PRIMARY CILIA IN ENDOCRINE DISEASE AND OBESITY
    HALL 9
    Chairs: P Chapple (London) & L Guasti (London)
    S5.1
    Symposium 5
    Primary cilia in health and disease
    London, UK
    S5.2
    Symposium 5
    The importance of primary cilia in adrenal development
    S5.3
    Symposium 5
    The importance of primary cilia in adipogenic differentiation
    Strasbourg, France
    S5.4
    Symposium 5
    Primary cilia dysfunction causes impaired leptin signalling and obesity
    Iowa City, USA
    16:30 - 17:30 
    Clinical Debate
    THIS HOUSE BELIEVES THAT THERE IS AN IMPORTANT ROLE FOR BONE MARKERS IN THE CLINICAL MANAGEMENT OF PATIENTS WITH OSTEOPOROSIS
    HALL 1
    Chair: R Eastell (Sheffield)
    For: W Fraser (Liverpool) & Against: A McLellan (Glasgow)
    D1.2
    Clinical Debate
    This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
    D1.1
    Clinical Debate
    This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
    17:30 - 18:15 
    Meet the Expert 1 (repeat)
    ABNORMAL GROWTH AND PUBERTY PRESENTING IN 'LATE ADOLESCENCE'
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 11
    Chair: H Gleeson (Manchester)
    Expert: P Clayton (Manchester)
    17:30 - 18:15 
    Meet the Expert 2 (repeat)
    THE DIFFICULT CUSHING'S OR NELSON'S PATIENT
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 1
    Chair: A Grossman (London)
    Expert: X Bertanga (Paris, France)
    18:30 - 19:00 
    SOCIETY FOR ENDOCRINOLOGY TRANSATLANTIC MEDAL
    HALL 1
    Chair: P Stewart (Birmingham)
    PL3
    SOCIETY FOR ENDOCRINOLOGY TRANSATLANTIC MEDAL
    Growth hormone (GH), GH antagonists, GH receptor knockouts; getting old and fat
    19:30 - 23:00 
    CONFERENCE DINNER
    HALL 4

    07:15 - 08:00 
    Meet the Expert 4
    MANAGING TURNER SYNDROME THROUGH CHILDHOOD AND ADOLESCENCE
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 11
    Chair: D Dunger (Cambridge)
    Expert: M Donaldson (Glasgow)
    07:15 - 08:00 
    Meet the Expert 5
    LATE EFFECTS OF CANCER THERAPYY MANAGING THE SILENT EPIDEMIC OF ENDOCRINOPATHIES IN CANCER SURVIVORS
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 10
    Chair: A Toogood (Birmingham)
    Expert: R Ross (Sheffield)
    08:10 - 08:55 
    SOCIETY FOR ENDOCRINOLOGY ANNUAL GENERAL MEETING
    HALL 1
    09:00 - 11:00 
    Symposium 6
    NOVEL APPLICATION OF THYROID HORMONE ANALOGUES - THYROID HORMONES, THINKING OUTSIDE THE CAPSULE
    HALL 11
    Chairs: M Vanderpump (London) & V Smith (Birmingham)
    S6.1
    Symposium 6
    Thyroid hormone action - genomic and non-genomic effects
    S6.2
    Symposium 6
    Physiology and pharmacology of iodothyronamines (thyroid hormone metabolites)
    Portland, USA
    S6.3
    Symposium 6
    The action of thyroid hormone in vascular tissues
    New York, USA
    S6.4
    Symposium 6
    Liver-selective TR agonists for the treatment of dyslipidemia
    Stockholm, Sweden
    09:00 - 11:00 
    Symposium 7
    EAT, BOND, REPRODUCE, WHAT THE HYPOTHALAMUS DICTATES
    HALL 1
    Chairs: G Leng (Edinburgh) & C Jayasena (London)
    S7.1
    Symposium 7
    Vasopressin and social bonding: the role of the olfactory bulb
    S7.2
    Symposium 7
    The role of tanycytes in the regulation of the reproductive axis
    Lille, France
    S7.3
    Symposium 7
    Metabolic regulation of the reproductive axis
    Melbourne, Australia
    S7.4
    Symposium 7
    Neurokinin B, kisspeptin and the regulation of puberty
    Washington, USA
    09:00 - 11:00 
    Nurses Session 1
    TURNER/KLINEFELTER'S/NOONAN'S SYNDROME
    SUPPORTED BY KLINEFELTER'S SYNDROME ASSOCIATION
    HALL 10
    Chairs: S Llahana (London) & K Powell (Norfolk)
    N1.1
    Nurses Session 1
    Turners/Klinefelters/Noonans Syndrome
    N1.2
    Nurses Session 1
    Klinefelter's case presentation
    N1.3
    Nurses Session 1
    Living with TS: an adult viewpoint
    N1.4
    Nurses Session 1
    Klinefelter's Syndrome Association
    11:00 - 11:30 
    TEA & COFFEE
    HALL 3
    11:30 - 12:05 
    SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2010
    HALL 1
    Chair: P Stewart (Birmingham)
    PL4
    SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2010
    Adrenal lumps and bumps – progress in the management of adrenocortical tumours
    Würzburg, Germany
    12:05 - 12:40 
    SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2011
    HALL 1
    Chair: G Williams (London)
    PL5
    SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2011
    Adrenal interlinking in Europe
    Paris, France
    12:40 - 14:15 
    LUNCH & POSTERS
    HALL 3
    14:15 - 16:15 
    Symposium 8
    HORMONES AND BONE METABOLISM
    HALL 11
    Chairs: S Orme (Leeds) & M Aye (Kingston-upon-Hull)
    S8.1
    Symposium 8
    Fracture risk in patients with diabetes
    Dresden, Germany
    S8.2
    Symposium 8
    Muscle weakness, falls and vitamin D deficiency
    S8.3
    Symposium 8
    Effects of male hypogonadism on bone metabolism
    Gent, Belgium
    S8.4
    Symposium 8
    Protecting bone density during aromatase inhibitor therapy
    14:15 - 16:15 
    Clinical Management Workshop 3
    PITUITARY RADIOTHERAPY: WHAT ARE THE OPTIONS
    SUPPORTED BY CLINICAL ENDOCRINOLOGY AND THE PITUITARY FOUNDATION
    HALL 1
    Chairs: W Drake (London) & M Sherlock (Birmingham)
    CM3.1
    Clinical Management Workshop 3
    Fractionated RT: efficacy and recent advances
    CM3.2
    Clinical Management Workshop 3
    Focussed radiotherapy as primary treatment for pituitary disease
    CM3.3
    Clinical Management Workshop 3
    Focussed radiotherapy as salvage treatment for pituitary disease
    CM3.4
    Clinical Management Workshop 3
    Radiotherapy, cognition and cerebrovascular disease: what is the evidence?
    Birmingham, UK
    14:15 - 16:15 
    Nurses' Session 2
    HYPERTHYROIDISM
    HALL 10
    Chairs: N Kieffer (Leicester) & J Munday (Portsmouth)
    N2.1
    Nurses' Session 2
    Overview of causes and treatment options
    N2.2
    Nurses' Session 2
    Nurse led thyroid clinic
    N2.3
    Nurses' Session 2
    Case presentation
    N2.4
    Nurses' Session 2
    Hyperthyroidism
    14:15 - 15:00 
    Meet the Expert 8
    APPLICATIONS OF NEXT GENERATION SEQUENCING
    HALL 9
    Chair: L Metherell (London)
    Expert: D Buck (Oxford)
    15:15 - 16:15 
    Meet the Expert 9
    MICRORNAS - WHAT ARE THEY, HOW TO MEASURE AND MANIPULATE THEM?
    HALL 9
    Chair: P Igaz (Budapest, Hungary)
    Expert: L O'Driscoll (Dublin, Ireland)
    16:15 - 16:45 
    TEA & COFFEE
    HALL 3
    16:45 - 17:20 
    SOCIETY FOR ENDOCRINOLOGY MEDAL LECTURE
    HALL 1
    Chair: J Buckingham (London)
    PL6
    SOCIETY FOR ENDOCRINOLOGY MEDAL LECTURE
    The bare bones of thyroid hormones
    17:20 - 17:50 
    AWARDS CEREMONY
    HALL 1
    Chair: J Buckingham (London)
    18:00 - 18:35 
    BRITISH THYROID ASSOCIATION PITT-RIVERS LECTURE
    SUPPORTED BY THE CLINICAL ENDOCRINOLOGY TRUST
    HALL 1
    Chair: J Franklyn (Birmingham)
    PL7
    BRITISH THYROID ASSOCIATION PITT-RIVERS LECTURE
    An expanded view on resistance to thyroid hormone
    Chicago, USA
    18:35 - 20:35 
    Satellite sessions

    07:30 - 08:15 
    Meet the Expert 6
    ASSESSING THE FRACTURE RISK AND RESPONSE TO THERAPY IN OSTEOPOROSIS
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 11
    Chair: A McLellan (Glasgow)
    Expert: E McCloskey (Sheffield)
    07:30 - 08:15 
    Meet the Expert 7
    MANAGING INFERTILITY
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 9
    Chair: A Coomarasamy (Birmingham)
    Expert: S Lavery (London)
    08:30 - 09:00 
    CLINICAL ENDOCRINOLOGY TRUST VISITING PROFESSOR LECTURE
    SUPPORTED BY THE CLINICAL ENDOCRINOLOGY TRUST
    HALL 1
    Chair: A Weetman (Sheffield)
    PL8
    CLINICAL ENDOCRINOLOGY TRUST VISITING PROFESSOR LECTURE
    Genetics of thyroid cancer: clinical and therapeutic implications
    09:00 - 09:30 
    CLINICAL ENDOCRINOLOGY TRUST LECTURE
    SUPPORTED BY THE CLINICAL ENDOCRINOLOGY TRUST
    HALL 1
    Chair: S Judd (Adelaide, Australia)
    PL9
    CLINICAL ENDOCRINOLOGY TRUST LECTURE
    Pituitary tumours: the goal is shrinking
    09:30 - 10:15 
    CLINICAL GUIDELINES
    HALL 1
    Chair: P Trainer (Manchester)
    CG1.1
    CLINICAL GUIDELINES
    Management of pituitary apoplexy
    10:15 - 10:45 
    TEA & COFFEE
    HALL 3
    10:45 - 12:45 
    Clinical Management Workshop 4
    MANAGEMENT OF DISORDERS OF SEX DEVELOPMENT (DSD) ACROSS THE LIFESPAN
    SUPPORTED BY CLINICAL ENDOCRINOLOGY AND TURNER SYNDROME SUPPORT SOCIETY
    HALL 11
    Chairs: F Ahmed (Glasgow) & J Idkowiak (Birmingham)
    CM4.1
    Clinical Management Workshop 4
    The clinical spectrum of DSD
    CM4.2
    Clinical Management Workshop 4
    Presentation in adolescence
    Lubeck, Germany
    CM4.3
    Clinical Management Workshop 4
    Transitional care of the young person with DSD
    CM4.4
    Clinical Management Workshop 4
    New approaches to molecular diagnosis
    London, UK
    10:45 - 12:45 
    Symposium 9
    DOPING PERFORMANCE ENHANCING SUBSTANCES IN SPORT AND THEIR DETECTION
    HALL 1
    Chairs: D Cowan (London) & A Taylor (Birmingham)
    S9.1
    Symposium 9
    Anabolic steroids
    S9.2
    Symposium 9
    Compounds enhancing oxygen delivery
    Oslo, Norway
    S9.3
    Symposium 9
    Growth hormone
    S9.4
    Symposium 9
    Detection: gene and cellular technologies
    San Diego, USA
    10:45 - 12:45 
    SENIOR ENDOCRINOLOGISTS' SESSION
    HALL 9
    Chairs: D Anderson (Montecastello di Vibio, Italy) & G Vinson (London)
    SE1.1
    SENIOR ENDOCRINOLOGISTS' SESSION
    The metamorphosis of testosterone from a sex steroid to a universal health factor
    Muenster, Germany
    SE1.2
    SENIOR ENDOCRINOLOGISTS' SESSION
    Will we ever discover the mechanism of hormone action?
    SE1.3
    SENIOR ENDOCRINOLOGISTS' SESSION
    An exploration of colour theory
    SE1.4
    SENIOR ENDOCRINOLOGISTS' SESSION
    Two seminal case reports of the law breaking the law
    Montecastello di Vibio, Italy
    SE1.5
    SENIOR ENDOCRINOLOGISTS' SESSION
    The art of medicine
    SE1.6
    SENIOR ENDOCRINOLOGISTS' SESSION
    The endocrinology of extra-marital affairs
    12:45 - 13:30 
    Meet the Expert 3 (repeat)
    VITAMIN D DEFICIENCY, WHEN AND HOW TO TREAT
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 11
    Chair: S Orme (Leeds)
    Expert: P Selby (Manchester)
    12:45 - 13:30 
    Meet the Expert 4 (repeat)
    MANAGING TURNER SYNDROME THROUGH CHILDHOOD AND ADOLESCENCE
    SUPPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 1
    Chair: D Dunger (Cambridge)
    Expert: M Donaldson (Glasgow)
    12:45 - 13:30 
    Meet the Expert 5 (repeat)
    LATE EFFECTS OF CANCER THERAPY MANAGING THE SILENT EPIDEMIC OF ENDOCRINOPATHIES IN CANCER SURVIVORS
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 9
    Chair: A Toogood (Birmingham)
    Expert: R Ross (Sheffield)
    13:30 - 14:15 
    Meet the Expert 6 (repeat)
    ASSESSING FRACTURE RISK AND RESPONSE TO THERAPY IN OSTEOPOROSIS
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 11
    Chair: A McLellan (Glasgow)
    Expert: E McCloskey (Sheffield)
    13:30 - 14:15 
    Meet the Expert 7 (repeat)
    MANAGING INFERTILITY
    SUPPORTED BY CLINICAL ENDOCRINOLOGY
    HALL 1
    Chair: A Coomarasamy (Birmingham)
    Expert: S Lavery (London)
J Achermann
London, UK
Thu 14 12:15
CM4.4
Clinical Management Workshop 4
New approaches to molecular diagnosis
London, UK
A Allahabadia
Mon 11 14:00
CM1.2
Clinical Management Workshop 1
Thyroid storm, aranulocytosis, vasculitis, hepatitis - what to do next?
Bruno Allolio
Würzburg, Germany
Wed 13 11:30
PL4
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2010
Adrenal lumps and bumps – progress in the management of adrenocortical tumours
Würzburg, Germany
D Anderson
Montecastello di Vibio, Italy
Thu 14 11:45
SE1.4
SENIOR ENDOCRINOLOGISTS' SESSION
Two seminal case reports of the law breaking the law
Montecastello di Vibio, Italy
R Andrews
Mon 11 12:00
SIG2.3
OBESITY SPECIAL INTEREST GROUP
Pre- and post-operative management of patients undergoing bariatric surgery
B Angelin
Stockholm, Sweden
Wed 13 10:30
S6.4
Symposium 6
Liver-selective TR agonists for the treatment of dyslipidemia
Stockholm, Sweden
W Arlt
Tue 12 09:15
CM2.3
Clinical Management Workshop 2
Adrenal disorders in pregnancy
Dr John Ayuk
Birmingham, UK
Wed 13 15:45
CM3.4
Clinical Management Workshop 3
Radiotherapy, cognition and cerebrovascular disease: what is the evidence?
Birmingham, UK
L Bartalena
Varese, Italy
Mon 11 14:30
CM1.3
Clinical Management Workshop 1
The management of Graves' opthalmopathy and dermopathy
Varese, Italy
J Barth
Mon 11 12:30
SIG3.4
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of hyperandrogenism
A Bartke
Springfield, USA
Tue 12 14:00
S4.1
Symposium 4
The aging process - somatotrophic axis and calorie restriction
Springfield, USA
D Bassett
Wed 13 09:00
S6.1
Symposium 6
Thyroid hormone action - genomic and non-genomic effects
Philip Beales
London, UK
Tue 12 16:30
S5.1
Symposium 5
Primary cilia in health and disease
London, UK
G Beckett
Mon 11 12:00
SIG3.3
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of hypothyroidism
P Belchetz
Thu 14 11:25
SE1.3
SENIOR ENDOCRINOLOGISTS' SESSION
An exploration of colour theory
X Bertagna
Paris, France
Wed 13 11:30
PL5
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2011
Adrenal interlinking in Europe
Paris, France
J Bevan
Thu 14 09:00
PL9
CLINICAL ENDOCRINOLOGY TRUST LECTURE
Pituitary tumours: the goal is shrinking
M Bono
Tue 12 14:00
YE1.1
Young Endocrinologists' Symposium
Research in clinical academia
M Brada
Wed 13 14:15
CM3.1
Clinical Management Workshop 3
Fractionated RT: efficacy and recent advances
T Carpenter
New Haven, USA
Mon 11 11:30
SIG1.2
BONE AND MINERAL SPECIAL INTEREST GROUP
Hypophosphataemic rickets
New Haven, USA
H Chalal
Mon 11 18:40
YEP1.2
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Clinical, genetic and molecular characterisation of patients with familial isolated pituitary
S Chan
Tue 12 08:15
CM2.1
Clinical Management Workshop 2
Hypothyroidism and euthyroid antibody-positive patients
I Clarke
Melbourne, Australia
Wed 13 10:00
S7.3
Symposium 7
Metabolic regulation of the reproductive axis
Melbourne, Australia
H Cleaver
Wed 13 10:20
N1.3
Nurses Session 1
Living with TS: an adult viewpoint
M Clementi
Padova, Italy
Tue 12 08:45
CM2.2
Clinical Management Workshop 2
Treatment of hyperthyroidism in pregnancy-risk for the unborn
Padova, Italy
R Coleman
Wed 13 15:45
S8.4
Symposium 8
Protecting bone density during aromatase inhibitor therapy
G Conway
Wed 13 09:00
N1.1
Nurses Session 1
Turners/Klinefelters/Noonans Syndrome
Thu 14 11:45
CM4.3
Clinical Management Workshop 4
Transitional care of the young person with DSD
S Cook
Wed 13 10:40
N1.4
Nurses Session 1
Klinefelter's Syndrome Association
M Cooper
Mon 11 12:00
SIG1.3
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteogenesis imperfecta
P Davis
New York, USA
Wed 13 10:00
S6.3
Symposium 6
The action of thyroid hormone in vascular tissues
New York, USA
C Dayan
Mon 11 15:00
CM1.4
Clinical Management Workshop 1
New therapies for Graves' Disease
S Ellard
Mon 11 14:00
S1.2
Symposium 1
The diverse phenotypes of potassium ATP channel mutations
J Fagin
Thu 14 08:30
PL8
CLINICAL ENDOCRINOLOGY TRUST VISITING PROFESSOR LECTURE
Genetics of thyroid cancer: clinical and therapeutic implications
J Franklyn
Wed 13 14:15
N2.1
Nurses' Session 2
Overview of causes and treatment options
B Fraser
Tue 12 16:30
D1.2
Clinical Debate
This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
P Friedl
Nijmegen, Netherlands
Mon 11 14:10
AP1.2
Applied Physiology Workshop
Imaging of cell migration and invasion
Nijmegen, Netherlands
T Friedmann
San Diego, USA
Thu 14 12:15
S9.4
Symposium 9
Detection: gene and cellular technologies
San Diego, USA
P Fuller
Melbourne, Australia
Tue 12
PL2
SOCIETY FOR ENDOCRINOLOGY HOFFENBERG INTERNATIONAL MEDAL LECTURE
Aldosterone action and the mineralocorticoid receptor
Melbourne, Australia
C Gregson
Mon 11 11:00
SIG1.1
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteopetrosis and other causes of high bone mass
A Hanyaloglu
Tue 12 15:00
YE1.3
Young Endocrinologists' Symposium
Postdoctoral research - the things I wish I knew
P Hemmersbach
Oslo, Norway
Thu 14 11:15
S9.2
Symposium 9
Compounds enhancing oxygen delivery
Oslo, Norway
O Hiort
Lubeck, Germany
Thu 14 11:15
CM4.2
Clinical Management Workshop 4
Presentation in adolescence
Lubeck, Germany
D Hochhauser
Mon 11 17:30
S2.4
Symposium 2
New horizons in therapy
L Hofbauer
Dresden, Germany
Wed 13 14:15
S8.1
Symposium 8
Fracture risk in patients with diabetes
Dresden, Germany
R Holt
Thu 14 11:45
S9.3
Symposium 9
Growth hormone
I Hughes
Thu 14 10:45
CM4.1
Clinical Management Workshop 4
The clinical spectrum of DSD
D Johnson
Mon 11 12:30
SIG2.4
OBESITY SPECIAL INTEREST GROUP
Bariatric surgery - a cure for diabetes?
J Kaufman
Gent, Belgium
Wed 13 15:15
S8.3
Symposium 8
Effects of male hypogonadism on bone metabolism
Gent, Belgium
A Kicman
Thu 14 10:45
S9.1
Symposium 9
Anabolic steroids
M Kidd
New Haven, USA
Mon 11 16:00
S2.1
Symposium 2
Signalling pathways in neuroendocrine tumours
New Haven, USA
P King
Tue 12 17:00
S5.2
Symposium 5
The importance of primary cilia in adrenal development
J Kopchick
Tue 12 18:30
PL3
SOCIETY FOR ENDOCRINOLOGY TRANSATLANTIC MEDAL
Growth hormone (GH), GH antagonists, GH receptor knockouts; getting old and fat
J Lenders
Nijmegen, Netherlands
Tue 12 09:45
CM2.4
Clinical Management Workshop 2
Phaeochromocytoma in pregnancy
Nijmegen, Netherlands
W Lichtenbelt
Maastrict, Netherlands
Tue 12 08:15
S3.1
Symposium 3
Can we make more brown adipose tissue to treat obesity?
Maastrict, Netherlands
J Lord
Tue 12 15:00
S4.3
Symposium 4
DHEA, DHEAS and immunosenescence
M Ludwig
Wed 13 09:00
S7.1
Symposium 7
Vasopressin and social bonding: the role of the olfactory bulb
A MacLullich
Tue 12 15:30
S4.4
Symposium 4
Aging, hormones and cognition in humans
S Mahajan
Mon 11 14:50
AP1.3
Applied Physiology Workshop
CARS microscopy as a novel tool in cell imaging
V Marion
Strasbourg, France
Tue 12 17:30
S5.3
Symposium 5
The importance of primary cilia in adipogenic differentiation
Strasbourg, France
T Masud
Wed 13 14:45
S8.2
Symposium 8
Muscle weakness, falls and vitamin D deficiency
L Matthews
Mon 11 18:10
YEP1.1
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Novel glucocorticoid effects - signaling from the membrane to the nucleus
A McLellan
Tue 12 16:30
D1.1
Clinical Debate
This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
A McNeilly
Tue 12 14:30
YE1.2
Young Endocrinologists' Symposium
Managing your research degree
P Mollard
Montpellier, France
Mon 11 13:30
AP1.1
Applied Physiology Workshop
Cellular imaging in the pituitary - in vivo confocal microscopy
Montpellier, France
V Navarro
Washington, USA
Wed 13 10:30
S7.4
Symposium 7
Neurokinin B, kisspeptin and the regulation of puberty
Washington, USA
E Nieschlag
Muenster, Germany
Thu 14 10:45
SE1.1
SENIOR ENDOCRINOLOGISTS' SESSION
The metamorphosis of testosterone from a sex steroid to a universal health factor
Muenster, Germany
T Olbers
Mon 11 11:30
SIG2.2
OBESITY SPECIAL INTEREST GROUP
Gut, hormones, weight loss and metabolic improvement after bariatric surgery
K Owen
Mon 11 14:30
S1.3
Symposium 1
Using biomarkers to differentiate subtypes of MODY
D Papadopoulou
Wed 13 15:45
N2.4
Nurses' Session 2
Hyperthyroidism
S Pearce
Newcastle, UK
Mon 11 13:30
CM1.1
Clinical Management Workshop 1
Autoimmune hyperthyroidism - a spectrum of causes
Newcastle, UK
D Perez-Tilve
Cincinatti, USA
Mon 11 11:00
SIG2.1
OBESITY SPECIAL INTEREST GROUP
Gut hormone based polypharmacy - same benefits without the surgery?
Cincinatti, USA
J Perry
Mon 11 15:00
S1.4
Symposium 1
Genome-wide association studies for Type 2 diabetes
P Pickett
Wed 13 10:00
N1.2
Nurses Session 1
Klinefelter's case presentation
V Plagnol
Mon 11 13:30
S1.1
Symposium 1
Immune mechanisms involved in Type 1 diabetes - insights from genetics
V Prevot
Lille, France
Wed 13 09:30
S7.2
Symposium 7
The role of tanycytes in the regulation of the reproductive axis
Lille, France
P Rao
Mon 11 16:00
OC1.1
Oral Communications 1
Thyroid hormones in the euthyroid range predict subsequent body mass composition in women - the OPUS study
S Refetoff
Chicago, USA
Wed 13 18:00
PL7
BRITISH THYROID ASSOCIATION PITT-RIVERS LECTURE
An expanded view on resistance to thyroid hormone
Chicago, USA
J Rowe
Wed 13 14:45
CM3.2
Clinical Management Workshop 3
Focussed radiotherapy as primary treatment for pituitary disease
V Sanderson
Wed 13 14:45
N2.2
Nurses' Session 2
Nurse led thyroid clinic
T Scanlan
Portland, USA
Wed 13 09:30
S6.2
Symposium 6
Physiology and pharmacology of iodothyronamines (thyroid hormone metabolites)
Portland, USA
C Selman
Tue 12 14:30
S4.2
Symposium 4
Mechanisms: insulin sensitivity, AMPK and lifespan
Robert Semple
Edinburgh, UK
Tue 12 09:15
S3.3
Symposium 3
The link between insulin resistance, dyslipidaemia and fatty liver
Edinburgh, UK
V Sheffield
Iowa City, USA
Tue 12 18:00
S5.4
Symposium 5
Primary cilia dysfunction causes impaired leptin signalling and obesity
Iowa City, USA
C Shoulders
Tue 12 09:45
S3.4
Symposium 3
What you need to know about the genetics of hyperlipidaemia
E Simpson
Melbourne, Australia
Tue 12
PL1
SOCIETY FOR ENDOCRINOLOGY DALE MEDAL LECTURE
Aromatase, obesity and breast cancer - old wine in new bottles
Melbourne, Australia
S Suliman
Tue 12 08:45
S3.2
Symposium 3
Familial partial lipodystrophy - an introduction and the importance of diagnosing FPLD
F Swords
Wed 13 15:15
CM3.3
Clinical Management Workshop 3
Focussed radiotherapy as salvage treatment for pituitary disease
J Tata
Thu 14 11:05
SE1.2
SENIOR ENDOCRINOLOGISTS' SESSION
Will we ever discover the mechanism of hormone action?
C Thirwell
Mon 11 16:30
S2.2
Symposium 2
DNA methylation profiling of neuroendocrine tumours
A Toft
Thu 14 12:05
SE1.5
SENIOR ENDOCRINOLOGISTS' SESSION
The art of medicine
A Uitterlinden
Rotterdam, Netherlands
Mon 11 12:30
SIG1.4
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteoporosis
Rotterdam, Netherlands
J Valle
Mon 11 17:00
S2.3
Symposium 2
Tyrosine kinase inhibitors for neuroendocrine tumours
G Vinson
Thu 14 12:25
SE1.6
SENIOR ENDOCRINOLOGISTS' SESSION
The endocrinology of extra-marital affairs
J Walsh
Mon 11 11:00
SIG3.1
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of Vitamin D deficiency
C Wang
Torrence, USA
Mon 11 11:30
SIG3.2
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of male hypogonadism
Torrence, USA
J Wass
Thu 14 09:30
CG1.1
CLINICAL GUIDELINES
Management of pituitary apoplexy
S Webster
Tue 12 15:30
YE1.4
Young Endocrinologists' Symposium
Commercialisation and IP – translating scientific research
G Williams
Wed 13 16:45
PL6
SOCIETY FOR ENDOCRINOLOGY MEDAL LECTURE
The bare bones of thyroid hormones
D Wright
Wed 13 15:15
N2.3
Nurses' Session 2
Case presentation
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 8
Mon 11 13:30
Symposium 1
ALL YOU NEED TO KNOW ABOUT THE GENETICS OF DIABETES (TYPE 1 & 2 AND MODY)
HALL 11
Chairs: S Farooqi (Cambridge) & S Finer (London)
Mon 11 13:30
S1.1
Symposium 1
Immune mechanisms involved in Type 1 diabetes - insights from genetics
Mon 11 14:00
S1.2
Symposium 1
The diverse phenotypes of potassium ATP channel mutations
Mon 11 14:30
S1.3
Symposium 1
Using biomarkers to differentiate subtypes of MODY
Mon 11 15:00
S1.4
Symposium 1
Genome-wide association studies for Type 2 diabetes
Mon 11 16:00
Symposium 2
NOVEL PATHWAYS AND TREATMENTS IN NEUROENDOCRINE TUMOURS
SUPPORTED BY THE ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS
HALL 11
Chairs: P Trainer (Manchester) & U Srirangalingam (London)
Mon 11 16:00
S2.1
Symposium 2
Signalling pathways in neuroendocrine tumours
New Haven, USA
Mon 11 16:30
S2.2
Symposium 2
DNA methylation profiling of neuroendocrine tumours
Mon 11 17:00
S2.3
Symposium 2
Tyrosine kinase inhibitors for neuroendocrine tumours
Mon 11 17:30
S2.4
Symposium 2
New horizons in therapy
Tue 12 08:15
Symposium 3
FAT ENDOCRINOLOGY: DISORDERS OF ADIPOSE TISSUE AND LIPIDS IMPORTANT TO THE ENDOCRINOLOGIST
HALL 1
Chairs: W Dhillo (London) & A Sam (London)
Tue 12 08:15
S3.1
Symposium 3
Can we make more brown adipose tissue to treat obesity?
Maastrict, Netherlands
Tue 12 08:45
S3.2
Symposium 3
Familial partial lipodystrophy - an introduction and the importance of diagnosing FPLD
Tue 12 09:15
S3.3
Symposium 3
The link between insulin resistance, dyslipidaemia and fatty liver
Edinburgh, UK
Tue 12 09:45
S3.4
Symposium 3
What you need to know about the genetics of hyperlipidaemia
Tue 12 14:00
Symposium 4
ENDOCRINE REGULATION OF AGEING
HALL 10
Chairs: J Kopchick (Athens, GA, USA) & C Moss (London)
Tue 12 14:00
S4.1
Symposium 4
The aging process - somatotrophic axis and calorie restriction
Springfield, USA
Tue 12 14:30
S4.2
Symposium 4
Mechanisms: insulin sensitivity, AMPK and lifespan
Tue 12 15:00
S4.3
Symposium 4
DHEA, DHEAS and immunosenescence
Tue 12 15:30
S4.4
Symposium 4
Aging, hormones and cognition in humans
Tue 12 16:30
Symposium 5
THE NOVEL ROLE OF PRIMARY CILIA IN ENDOCRINE DISEASE AND OBESITY
HALL 9
Chairs: P Chapple (London) & L Guasti (London)
Tue 12 16:30
S5.1
Symposium 5
Primary cilia in health and disease
London, UK
Tue 12 17:00
S5.2
Symposium 5
The importance of primary cilia in adrenal development
Tue 12 17:30
S5.3
Symposium 5
The importance of primary cilia in adipogenic differentiation
Strasbourg, France
Tue 12 18:00
S5.4
Symposium 5
Primary cilia dysfunction causes impaired leptin signalling and obesity
Iowa City, USA
Wed 13 09:00
Symposium 6
NOVEL APPLICATION OF THYROID HORMONE ANALOGUES - THYROID HORMONES, THINKING OUTSIDE THE CAPSULE
HALL 11
Chairs: M Vanderpump (London) & V Smith (Birmingham)
Wed 13 09:00
S6.1
Symposium 6
Thyroid hormone action - genomic and non-genomic effects
Wed 13 09:30
S6.2
Symposium 6
Physiology and pharmacology of iodothyronamines (thyroid hormone metabolites)
Portland, USA
Wed 13 10:00
S6.3
Symposium 6
The action of thyroid hormone in vascular tissues
New York, USA
Wed 13 10:30
S6.4
Symposium 6
Liver-selective TR agonists for the treatment of dyslipidemia
Stockholm, Sweden
Wed 13 09:00
Symposium 7
EAT, BOND, REPRODUCE, WHAT THE HYPOTHALAMUS DICTATES
HALL 1
Chairs: G Leng (Edinburgh) & C Jayasena (London)
Wed 13 09:00
S7.1
Symposium 7
Vasopressin and social bonding: the role of the olfactory bulb
Wed 13 09:30
S7.2
Symposium 7
The role of tanycytes in the regulation of the reproductive axis
Lille, France
Wed 13 10:00
S7.3
Symposium 7
Metabolic regulation of the reproductive axis
Melbourne, Australia
Wed 13 10:30
S7.4
Symposium 7
Neurokinin B, kisspeptin and the regulation of puberty
Washington, USA
Wed 13 14:15
Symposium 8
HORMONES AND BONE METABOLISM
HALL 11
Chairs: S Orme (Leeds) & M Aye (Kingston-upon-Hull)
Wed 13 14:15
S8.1
Symposium 8
Fracture risk in patients with diabetes
Dresden, Germany
Wed 13 14:45
S8.2
Symposium 8
Muscle weakness, falls and vitamin D deficiency
Wed 13 15:15
S8.3
Symposium 8
Effects of male hypogonadism on bone metabolism
Gent, Belgium
Wed 13 15:45
S8.4
Symposium 8
Protecting bone density during aromatase inhibitor therapy
No Session Type 3
Mon 11 13:00
LUNCH
HALL 3
Mon 11 15:30
TEA & COFFEE
HALL 3
Tue 12 07:00
Breakfast
HALL 9, 10 & 11 FOYER

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract